The Food and Drugs Authority (FDA) has announced the appointment of Professor Kwabena Frimpong-Manso Opuni as its new Acting Chief Executive Officer, effective Monday, July 14, 2025.

Before this appointment, Professor Opuni served as the Board Chairman of the FDA, a position in which he provided strategic oversight and governance for the Authority’s regulatory functions.

He takes over from Dr. Delese Mimi Darko, who has led the FDA since 2017 and was recently appointed Director-General of the Africa Medicines Agency, a continental regulatory body established to harmonise and strengthen oversight of medical products across Africa.

Announcing the change via its official X (formerly Twitter) platform, the FDA expressed confidence in Professor Opuni’s ability to advance the Authority’s core mandate of ensuring public health and safety.

“The Food & Drugs Authority is pleased to announce the appointment of Professor Kwabena Frimpong-Manso Opuni as its new Acting Chief Executive Officer effective Monday 14th July 2025,” the FDA stated.

In its message, the FDA said it looked forward to Professor Opuni’s leadership in deepening the Authority’s regulatory impact. “The FDA extends its warmest congratulations to Prof. Opuni on his appointment and looks forward to his leadership in advancing the Authority’s mandate of safeguarding public health and safety.”

Professor Opuni’s appointment comes at a time of increasing attention to food and drug safety in Ghana, with the FDA stepping up enforcement and public education campaigns on counterfeit medicines, substandard products, and food hygiene. His extensive academic and regulatory experience is expected to bolster the Authority’s efforts in these critical areas.